Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs755622

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr22:23894205 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>C
Variation Type
SNV Single Nucleotide Variation
Frequency
C=0.259300 (68634/264690, TOPMED)
C=0.258328 (36217/140198, GnomAD)
C=0.30544 (24010/78608, PAGE_STUDY) (+ 15 more)
C=0.20493 (5791/28258, 14KJPN)
C=0.22726 (4293/18890, ALFA)
C=0.20698 (3469/16760, 8.3KJPN)
C=0.2684 (1719/6404, 1000G_30x)
C=0.2668 (1336/5008, 1000G)
C=0.2080 (932/4480, Estonian)
C=0.1788 (689/3854, ALSPAC)
C=0.1775 (658/3708, TWINSUK)
C=0.2077 (608/2928, KOREAN)
C=0.163 (98/600, NorthernSweden)
G=0.395 (101/256, SGDP_PRJ)
C=0.171 (37/216, Qatari)
C=0.145 (31/214, Vietnamese)
C=0.20 (8/40, GENOME_DK)
G=0.45 (10/22, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
MIF-AS1 : Non Coding Transcript Variant
MIF : 2KB Upstream Variant
Publications
95 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 18890 G=0.77274 C=0.22726
European Sub 14286 G=0.81184 C=0.18816
African Sub 2946 G=0.5988 C=0.4012
African Others Sub 114 G=0.588 C=0.412
African American Sub 2832 G=0.5992 C=0.4008
Asian Sub 112 G=0.795 C=0.205
East Asian Sub 86 G=0.83 C=0.17
Other Asian Sub 26 G=0.69 C=0.31
Latin American 1 Sub 146 G=0.753 C=0.247
Latin American 2 Sub 610 G=0.736 C=0.264
South Asian Sub 98 G=0.71 C=0.29
Other Sub 692 G=0.747 C=0.253


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 G=0.740700 C=0.259300
gnomAD - Genomes Global Study-wide 140198 G=0.741672 C=0.258328
gnomAD - Genomes European Sub 75922 G=0.81772 C=0.18228
gnomAD - Genomes African Sub 42022 G=0.59174 C=0.40826
gnomAD - Genomes American Sub 13652 G=0.73667 C=0.26333
gnomAD - Genomes Ashkenazi Jewish Sub 3320 G=0.8488 C=0.1512
gnomAD - Genomes East Asian Sub 3128 G=0.8027 C=0.1973
gnomAD - Genomes Other Sub 2154 G=0.7642 C=0.2358
The PAGE Study Global Study-wide 78608 G=0.69456 C=0.30544
The PAGE Study AfricanAmerican Sub 32466 G=0.60229 C=0.39771
The PAGE Study Mexican Sub 10796 G=0.71693 C=0.28307
The PAGE Study Asian Sub 8306 G=0.7899 C=0.2101
The PAGE Study PuertoRican Sub 7914 G=0.7502 C=0.2498
The PAGE Study NativeHawaiian Sub 4534 G=0.8593 C=0.1407
The PAGE Study Cuban Sub 4224 G=0.7959 C=0.2041
The PAGE Study Dominican Sub 3826 G=0.7041 C=0.2959
The PAGE Study CentralAmerican Sub 2448 G=0.6949 C=0.3051
The PAGE Study SouthAmerican Sub 1980 G=0.7955 C=0.2045
The PAGE Study NativeAmerican Sub 1258 G=0.7281 C=0.2719
The PAGE Study SouthAsian Sub 856 G=0.773 C=0.227
14KJPN JAPANESE Study-wide 28258 G=0.79507 C=0.20493
Allele Frequency Aggregator Total Global 18890 G=0.77274 C=0.22726
Allele Frequency Aggregator European Sub 14286 G=0.81184 C=0.18816
Allele Frequency Aggregator African Sub 2946 G=0.5988 C=0.4012
Allele Frequency Aggregator Other Sub 692 G=0.747 C=0.253
Allele Frequency Aggregator Latin American 2 Sub 610 G=0.736 C=0.264
Allele Frequency Aggregator Latin American 1 Sub 146 G=0.753 C=0.247
Allele Frequency Aggregator Asian Sub 112 G=0.795 C=0.205
Allele Frequency Aggregator South Asian Sub 98 G=0.71 C=0.29
8.3KJPN JAPANESE Study-wide 16760 G=0.79302 C=0.20698
1000Genomes_30x Global Study-wide 6404 G=0.7316 C=0.2684
1000Genomes_30x African Sub 1786 G=0.5689 C=0.4311
1000Genomes_30x Europe Sub 1266 G=0.8175 C=0.1825
1000Genomes_30x South Asian Sub 1202 G=0.7804 C=0.2196
1000Genomes_30x East Asian Sub 1170 G=0.8043 C=0.1957
1000Genomes_30x American Sub 980 G=0.770 C=0.230
1000Genomes Global Study-wide 5008 G=0.7332 C=0.2668
1000Genomes African Sub 1322 G=0.5658 C=0.4342
1000Genomes East Asian Sub 1008 G=0.8036 C=0.1964
1000Genomes Europe Sub 1006 G=0.8141 C=0.1859
1000Genomes South Asian Sub 978 G=0.782 C=0.218
1000Genomes American Sub 694 G=0.764 C=0.236
Genetic variation in the Estonian population Estonian Study-wide 4480 G=0.7920 C=0.2080
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.8212 C=0.1788
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.8225 C=0.1775
KOREAN population from KRGDB KOREAN Study-wide 2928 G=0.7923 C=0.2077
Northern Sweden ACPOP Study-wide 600 G=0.837 C=0.163
SGDP_PRJ Global Study-wide 256 G=0.395 C=0.605
Qatari Global Study-wide 216 G=0.829 C=0.171
A Vietnamese Genetic Variation Database Global Study-wide 214 G=0.855 C=0.145
The Danish reference pan genome Danish Study-wide 40 G=0.80 C=0.20
Siberian Global Study-wide 22 G=0.45 C=0.55
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 22 NC_000022.11:g.23894205G>C
GRCh37.p13 chr 22 NC_000022.10:g.24236392G>C
MIF RefSeqGene NG_012099.1:g.4828G>C
GRCh38.p14 chr 22 alt locus HSCHR22_1_CTG7 NT_187633.1:g.130567G>C
Gene: MIF, macrophage migration inhibitory factor (plus strand) : 2KB Upstream Variant
Molecule type Change Amino acid[Codon] SO Term
MIF transcript NM_002415.2:c. N/A Upstream Transcript Variant
Gene: MIF-AS1, MIF antisense RNA 1 (minus strand)
Molecule type Change Amino acid[Codon] SO Term
MIF-AS1 transcript NR_038911.1:n.1697C>G N/A Non Coding Transcript Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: C (allele ID: 29398 )
ClinVar Accession Disease Names Clinical Significance
RCV000015433.2 Rheumatoid arthritis, systemic juvenile, susceptibility to Risk-Factor
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= C
GRCh38.p14 chr 22 NC_000022.11:g.23894205= NC_000022.11:g.23894205G>C
GRCh37.p13 chr 22 NC_000022.10:g.24236392= NC_000022.10:g.24236392G>C
MIF RefSeqGene NG_012099.1:g.4828= NG_012099.1:g.4828G>C
GRCh38.p14 chr 22 alt locus HSCHR22_1_CTG7 NT_187633.1:g.130567= NT_187633.1:g.130567G>C
MIF-AS1 transcript NR_038911.1:n.1697= NR_038911.1:n.1697C>G
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

95 SubSNP, 18 Frequency, 1 ClinVar submissions
No Submitter Submission ID Date (Build)
1 TSC-CSHL ss109873 Oct 05, 2000 (86)
2 LEE ss1546508 Oct 05, 2000 (92)
3 CGAP-GAI ss4322772 Jan 04, 2002 (102)
4 LEE ss4400195 May 29, 2002 (106)
5 LEE ss4431890 May 29, 2002 (106)
6 SC_JCM ss6136641 Feb 20, 2003 (111)
7 WI_SSAHASNP ss6659809 Feb 20, 2003 (111)
8 SC_SNP ss8012929 Apr 21, 2003 (114)
9 SNP500CANCER ss12675533 Nov 17, 2003 (118)
10 KYUGEN ss28458868 Sep 20, 2004 (123)
11 ABI ss44318452 Mar 13, 2006 (126)
12 EGP_SNPS ss49853574 Mar 13, 2006 (126)
13 STEJUSTINE-REGGEN ss51854285 Mar 16, 2006 (126)
14 CGM_KYOTO ss76870434 Dec 06, 2007 (129)
15 HGSV ss83358618 Dec 15, 2007 (130)
16 BCMHGSC_JDW ss91890517 Mar 24, 2008 (129)
17 HGSV ss107791785 Feb 04, 2009 (130)
18 1000GENOMES ss112573053 Jan 25, 2009 (130)
19 1000GENOMES ss114075818 Jan 25, 2009 (130)
20 ENSEMBL ss138340294 Dec 01, 2009 (131)
21 GMI ss157072584 Dec 01, 2009 (131)
22 COMPLETE_GENOMICS ss168973856 Jul 04, 2010 (132)
23 COMPLETE_GENOMICS ss171863597 Jul 04, 2010 (132)
24 BUSHMAN ss204060033 Jul 04, 2010 (132)
25 1000GENOMES ss228633441 Jul 14, 2010 (132)
26 1000GENOMES ss238033680 Jul 15, 2010 (132)
27 1000GENOMES ss244161043 Jul 15, 2010 (132)
28 BL ss255858988 May 09, 2011 (134)
29 GMI ss283601224 May 04, 2012 (137)
30 ILLUMINA ss483897104 May 04, 2012 (137)
31 ILLUMINA ss484293608 May 04, 2012 (137)
32 ILLUMINA ss536091739 Sep 08, 2015 (146)
33 TISHKOFF ss566579784 Apr 25, 2013 (138)
34 SSMP ss662508175 Apr 25, 2013 (138)
35 ILLUMINA ss780449419 Sep 08, 2015 (146)
36 ILLUMINA ss782392174 Sep 08, 2015 (146)
37 ILLUMINA ss835939296 Sep 08, 2015 (146)
38 EVA-GONL ss995253750 Aug 21, 2014 (142)
39 JMKIDD_LAB ss1082590741 Aug 21, 2014 (142)
40 1000GENOMES ss1366804849 Aug 21, 2014 (142)
41 DDI ss1429230731 Apr 01, 2015 (144)
42 EVA_GENOME_DK ss1579716120 Apr 01, 2015 (144)
43 EVA_UK10K_ALSPAC ss1639806500 Apr 01, 2015 (144)
44 EVA_UK10K_TWINSUK ss1682800533 Apr 01, 2015 (144)
45 EVA_DECODE ss1699322118 Apr 01, 2015 (144)
46 HAMMER_LAB ss1809747824 Sep 08, 2015 (146)
47 WEILL_CORNELL_DGM ss1938820108 Feb 12, 2016 (147)
48 ILLUMINA ss1959969443 Feb 12, 2016 (147)
49 JJLAB ss2030182466 Sep 14, 2016 (149)
50 ILLUMINA ss2094811088 Dec 20, 2016 (150)
51 USC_VALOUEV ss2158794645 Dec 20, 2016 (150)
52 HUMAN_LONGEVITY ss2246626460 Dec 20, 2016 (150)
53 ILLUMINA ss2633865914 Nov 08, 2017 (151)
54 ILLUMINA ss2633865915 Nov 08, 2017 (151)
55 ILLUMINA ss2633865916 Nov 08, 2017 (151)
56 GRF ss2704542943 Nov 08, 2017 (151)
57 GNOMAD ss2973362001 Nov 08, 2017 (151)
58 SWEGEN ss3019151620 Nov 08, 2017 (151)
59 ILLUMINA ss3022175671 Nov 08, 2017 (151)
60 BIOINF_KMB_FNS_UNIBA ss3028928661 Nov 08, 2017 (151)
61 CSHL ss3352794045 Nov 08, 2017 (151)
62 ILLUMINA ss3628511825 Oct 12, 2018 (152)
63 ILLUMINA ss3631817929 Oct 12, 2018 (152)
64 ILLUMINA ss3642212458 Oct 12, 2018 (152)
65 ILLUMINA ss3652637473 Oct 12, 2018 (152)
66 EGCUT_WGS ss3685656640 Jul 13, 2019 (153)
67 EVA_DECODE ss3708013476 Jul 13, 2019 (153)
68 ILLUMINA ss3725959728 Jul 13, 2019 (153)
69 ACPOP ss3743851001 Jul 13, 2019 (153)
70 EVA ss3759268630 Jul 13, 2019 (153)
71 PAGE_CC ss3772084261 Jul 13, 2019 (153)
72 KHV_HUMAN_GENOMES ss3822435851 Jul 13, 2019 (153)
73 EVA ss3825967210 Apr 27, 2020 (154)
74 EVA ss3835943334 Apr 27, 2020 (154)
75 EVA ss3841600199 Apr 27, 2020 (154)
76 EVA ss3847114572 Apr 27, 2020 (154)
77 SGDP_PRJ ss3890349493 Apr 27, 2020 (154)
78 KRGDB ss3940740775 Apr 27, 2020 (154)
79 VINODS ss4034756948 Apr 26, 2021 (155)
80 TOPMED ss5106066282 Apr 26, 2021 (155)
81 TOMMO_GENOMICS ss5232203357 Apr 26, 2021 (155)
82 1000G_HIGH_COVERAGE ss5310777641 Oct 16, 2022 (156)
83 EVA ss5316048847 Oct 16, 2022 (156)
84 EVA ss5440724490 Oct 16, 2022 (156)
85 HUGCELL_USP ss5502655310 Oct 16, 2022 (156)
86 EVA ss5512353916 Oct 16, 2022 (156)
87 1000G_HIGH_COVERAGE ss5618186543 Oct 16, 2022 (156)
88 SANFORD_IMAGENETICS ss5664312673 Oct 16, 2022 (156)
89 TOMMO_GENOMICS ss5793191332 Oct 16, 2022 (156)
90 YY_MCH ss5818629184 Oct 16, 2022 (156)
91 EVA ss5821944590 Oct 16, 2022 (156)
92 EVA ss5853359275 Oct 16, 2022 (156)
93 EVA ss5881460824 Oct 16, 2022 (156)
94 EVA ss5959165326 Oct 16, 2022 (156)
95 EVA ss5981127817 Oct 16, 2022 (156)
96 1000Genomes NC_000022.10 - 24236392 Oct 12, 2018 (152)
97 1000Genomes_30x NC_000022.11 - 23894205 Oct 16, 2022 (156)
98 The Avon Longitudinal Study of Parents and Children NC_000022.10 - 24236392 Oct 12, 2018 (152)
99 Genetic variation in the Estonian population NC_000022.10 - 24236392 Oct 12, 2018 (152)
100 The Danish reference pan genome NC_000022.10 - 24236392 Apr 27, 2020 (154)
101 gnomAD - Genomes NC_000022.11 - 23894205 Apr 26, 2021 (155)
102 KOREAN population from KRGDB NC_000022.10 - 24236392 Apr 27, 2020 (154)
103 Northern Sweden NC_000022.10 - 24236392 Jul 13, 2019 (153)
104 The PAGE Study NC_000022.11 - 23894205 Jul 13, 2019 (153)
105 Qatari NC_000022.10 - 24236392 Apr 27, 2020 (154)
106 SGDP_PRJ NC_000022.10 - 24236392 Apr 27, 2020 (154)
107 Siberian NC_000022.10 - 24236392 Apr 27, 2020 (154)
108 8.3KJPN NC_000022.10 - 24236392 Apr 26, 2021 (155)
109 14KJPN NC_000022.11 - 23894205 Oct 16, 2022 (156)
110 TopMed NC_000022.11 - 23894205 Apr 26, 2021 (155)
111 UK 10K study - Twins NC_000022.10 - 24236392 Oct 12, 2018 (152)
112 A Vietnamese Genetic Variation Database NC_000022.10 - 24236392 Jul 13, 2019 (153)
113 ALFA NC_000022.11 - 23894205 Apr 26, 2021 (155)
114 ClinVar RCV000015433.2 Oct 16, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1061516 Jan 18, 2001 (92)
rs3171731 Jul 03, 2002 (106)
rs36224310 Oct 25, 2006 (127)
rs58273618 May 24, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss83358618 NC_000022.8:22560945:G:C NC_000022.11:23894204:G:C (self)
ss91890517, ss112573053, ss114075818, ss168973856, ss171863597, ss204060033, ss255858988, ss283601224, ss484293608, ss1699322118 NC_000022.9:22566391:G:C NC_000022.11:23894204:G:C (self)
80343498, 44440454, 31394888, 5881059, 47918169, 17135866, 20862030, 42366473, 11310999, 90172664, 44440454, 9806561, ss228633441, ss238033680, ss244161043, ss483897104, ss536091739, ss566579784, ss662508175, ss780449419, ss782392174, ss835939296, ss995253750, ss1082590741, ss1366804849, ss1429230731, ss1579716120, ss1639806500, ss1682800533, ss1809747824, ss1938820108, ss1959969443, ss2030182466, ss2094811088, ss2158794645, ss2633865914, ss2633865915, ss2633865916, ss2704542943, ss2973362001, ss3019151620, ss3022175671, ss3352794045, ss3628511825, ss3631817929, ss3642212458, ss3652637473, ss3685656640, ss3743851001, ss3759268630, ss3825967210, ss3835943334, ss3841600199, ss3890349493, ss3940740775, ss5232203357, ss5316048847, ss5440724490, ss5512353916, ss5664312673, ss5821944590, ss5959165326, ss5981127817 NC_000022.10:24236391:G:C NC_000022.11:23894204:G:C (self)
RCV000015433.2, 105712478, 567376583, 1305730, 127028436, 381175229, 5970673869, ss2246626460, ss3028928661, ss3708013476, ss3725959728, ss3772084261, ss3822435851, ss3847114572, ss5106066282, ss5310777641, ss5502655310, ss5618186543, ss5793191332, ss5818629184, ss5853359275, ss5881460824 NC_000022.11:23894204:G:C NC_000022.11:23894204:G:C (self)
ss109873, ss1546508, ss4322772, ss4400195, ss4431890, ss6136641, ss6659809, ss8012929, ss12675533, ss28458868, ss44318452, ss49853574, ss51854285, ss76870434, ss107791785, ss138340294, ss157072584 NT_011520.12:3626960:G:C NC_000022.11:23894204:G:C (self)
ss4034756948 NT_187633.1:130566:G:C NC_000022.11:23894204:G:C (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

95 citations for rs755622
PMID Title Author Year Journal
16380915 Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Plenge RM et al. 2005 American journal of human genetics
16846490 Lemierre's syndrome and genetic polymorphisms: a case report. Constantin JM et al. 2006 BMC infectious diseases
17585860 Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Gao L et al. 2007 Translational research
18242614 Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Herder C et al. 2008 Atherosclerosis
18466472 Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm. Ding Y et al. 2007 BMC proceedings
18466513 Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. Mei L et al. 2007 BMC proceedings
19167373 The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Tereshchenko IP et al. 2009 Clinica chimica acta; international journal of clinical chemistry
19773451 Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Reyes-Gibby CC et al. 2009 Cancer epidemiology, biomarkers & prevention
19941661 A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. Lehmann LE et al. 2009 Journal of translational medicine
20169173 Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Kleemann R et al. 2010 Mediators of inflammation
20388640 Predictors of response to intra-articular steroid injection in psoriatic arthritis. Eder L et al. 2010 Rheumatology (Oxford, England)
20439102 Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population. Sadki K et al. 2010 Journal of genetics and genomics = Yi chuan xue bao
20447688 The MIF -173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Xue Y et al. 2010 Leukemia research
20471506 Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women. Swanberg M et al. 2010 Bone
20811626 Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Hildebrandt MA et al. 2010 PloS one
21553324 Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Choi HJ et al. 2011 Pediatric nephrology (Berlin, Germany)
21658257 The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity. Hollis-Moffatt JE et al. 2011 Arthritis research & therapy
22113576 Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. Aschebrook-Kilfoy B et al. 2012 Journal of cancer survivorship
22127710 Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Sreih A et al. 2011 Arthritis and rheumatism
22295056 Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. Christie JD et al. 2012 PloS one
22417159 DNA sequence variation and regulation of genes involved in pathogenesis of pulmonary tuberculosis. Qidwai T et al. 2012 Scandinavian journal of immunology
22568453 Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy. Gu S et al. 2012 Cancer science
22820623 Association of MIF-173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis. Xie Q et al. 2012 Human immunology
22939113 Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population. Zheng X et al. 2012 Ophthalmology
23402792 Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Llamas-Covarrubias MA et al. 2013 Cytokine
23913513 The role of macrophage migration inhibitory factor in autoimmune liver disease. Assis DN et al. 2014 Hepatology (Baltimore, Md.)
24151396 Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. Falvey JD et al. 2013 World journal of gastroenterology
24194192 MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Zhang C et al. 2013 Investigative ophthalmology & visual science
24337767 Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis. Schiotis R et al. 2014 Rheumatology international
24530749 Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. De la Cruz-Mosso U et al. 2014 Human immunology
24951298 Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome. Karakaya B et al. 2014 Cytokine
25124382 Methylenetetrahydrofolate reductase C667T polymorphism is associated with increased risk of coronary artery disease in a Chinese population. Chen W et al. 2014 Scandinavian journal of immunology
25294155 A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival. Baecklund F et al. 2014 BMC medical genetics
25329590 Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis. Tong X et al. 2015 Nephrology (Carlton, Vic.)
25600533 Lack of association between MIF gene -173G>C polymorphism with multiple sclerosis. Cevik B et al. 2015 In vivo (Athens, Greece)
25980667 Pharmacogenetics of treatment response in psoriatic arthritis. Jani M et al. 2015 Current rheumatology reports
26104808 That's not it, either-neither polymorphisms in PHOX2B nor in MIF are involved in sudden infant death syndrome (SIDS). Poetsch M et al. 2015 International journal of legal medicine
26345783 -173G/C polymorphism in the promoter of MIF is associated with hepatitis B virus infection in a Chinese Han population. Wang ZS et al. 2015 Genetics and molecular research
26426302 Association between Macrophage Migration Inhibitory Factor Gene Variation and Response to Glucocorticoid Treatment in Sudden Sensorineural Hearing Loss. Yazdani N et al. 2015 Audiology & neuro-otology
26541175 A genetic study of steroid-resistant nephrotic syndrome: relationship between polymorphism -173 G to C in the MIF gene and serum level MIF in children. Ramayani OR et al. 2016 Journal of developmental origins of health and disease
26542751 Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. Kuai SG et al. 2016 Infectious diseases (London, England)
26613086 Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis. Prieto-Pérez R et al. 2015 Journal of immunology research
26656832 Single nucleotide polymorphisms in cytokine MIF gene promoter region are closely associated with human susceptibility to tuberculosis in a southwestern province of China. Liu A et al. 2016 Infection, genetics and evolution
26667837 Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium. Lupiañez CB et al. 2015 Infection and immunity
26870349 Impact of single-nucleotide polymorphisms on radiation pneumonitis in cancer patients. Guo CX et al. 2016 Molecular and clinical oncology
26895959 Association Between MIF-AS rs755622 and Nephrolithiasis Risk in a Chinese Population. Ma G et al. 2016 Medical science monitor
26976591 Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis. Savva A et al. 2016 Proceedings of the National Academy of Sciences of the United States of America
27105877 Association of Genetic Polymorphisms in TNF and MIF Gene with the Risk of Primary Dysmenorrhea. Dogru HY et al. 2016 Biochemical genetics
27159875 Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Kautzky-Willer A et al. 2016 Endocrine reviews
27247801 Single Nucleotide Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome. Suvanto M et al. 2016 International journal of nephrology
27430937 Functional dyspepsia susceptibility is related to CD14, GNB3, MIF, and TRPV1 gene polymorphisms in the Greek population. Triantafyllou K et al. 2017 Neurogastroenterology and motility
27696094 A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients. Assis DN et al. 2016 Digestive diseases and sciences
27844180 Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women. Lin S et al. 2017 Clinical and experimental medicine
28578664 Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT5-8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects. Qian L et al. 2017 BMC cardiovascular disorders
28646884 The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis. Grygorczuk S et al. 2017 Journal of neuroinflammation
28657145 Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility. Sadek KH et al. 2017 Annals of human genetics
28668810 An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis. Bossini-Castillo L et al. 2017 The Journal of rheumatology
29208960 MIF -173 G > C (rs755622) Gene Polymorphism Modulates Tuberculosis Risk: Evidence from a Meta-analysis and Trial Sequential Analysis. Areeshi MY et al. 2017 Scientific reports
29545822 Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum. Illescas O et al. 2018 Frontiers in genetics
29661540 MIF functional polymorphisms (-794 CATT(5-8) and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. Castañeda-Moreno VA et al. 2018 Journal of neuroimmunology
29996006 MIF-173G/C (rs755622) polymorphism as a risk factor for acute lymphoblastic leukemia development in children. Sharaf-Eldein M et al. 2018 The journal of gene medicine
30140701 Genetic Variant rs755622 Regulates Expression of the Multiple Sclerosis Severity Modifier D-Dopachrome Tautomerase in a Sex-Specific Way. Han Z et al. 2018 BioMed research international
30182779 Genetic susceptibility to cerebrovascular disease: A systematic review. Griessenauer CJ et al. 2018 Journal of cerebral blood flow and metabolism
30628898 [Macrophage migration inhibitory factor (MIF) gene -173 G>C polymorphism and its relationship to coronary artery disease and type 2 diabetes]. Çoban N et al. 2019 Turk Kardiyoloji Dernegi arsivi
30747392 Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile. Baños-Hernández CJ et al. 2019 Clinical rheumatology
30903991 MIF 173 G>C variation was associated with depressive disorder in type 2 diabetes in an Iranian population. Hamidi AK et al. 2019 Psychoneuroendocrinology
31154458 Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention. Rajabi F et al. 2019 Archives of dermatological research
31370326 Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. Wirtz TH et al. 2019 International journal of molecular sciences
31422388 Macrophage Migration Inhibitory Factor -173 G>C Gene Polymorphism Is Associated with Increased Risk of Nephrotic Syndrome in Children. Sadeghi-Bojd S et al. 2019 Iranian journal of kidney diseases
31475028 Host Genetic Determinants of Hepatitis B Virus Infection. Zhang Z et al. 2019 Frontiers in genetics
31701681 Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico. Santoscoy-Ascencio G et al. 2020 Molecular genetics & genomic medicine
31745872 Genotyping Two Promoter Polymorphisms in the MIF Gene: A -794 CATT(5-8) Microsatellite Repeat and a -173 G/C SNP. Leng L et al. 2020 Methods in molecular biology (Clifton, N.J.)
31924846 MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study. Du GL et al. 2020 Scientific reports
31978276 Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer. Avalos-Navarro G et al. 2020 Journal of clinical laboratory analysis
31988876 Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Alsayed MAL et al. 2020 Pediatric gastroenterology, hepatology & nutrition
32044623 A novel gene-wide haplotype at the macrophage migration inhibitory factor (MIF) locus is associated with endometrioma. Chekini Z et al. 2020 European journal of obstetrics, gynecology, and reproductive biology
32560699 MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis. Li DY et al. 2020 BMC cardiovascular disorders
32800392 Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity. El-Mahdy RI et al. 2021 Heart & lung
32811420 Role of MIF-173G/C and Mbl2 Codon 54A/B Variants in the Risk of Multiple Myeloma: An Association Study. Pehlivan M et al. 2021 Endocrine, metabolic & immune disorders drug targets
32932965 The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery. Averdunk L et al. 2020 Journal of clinical medicine
33046033 Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis. Sakurai N et al. 2020 BMC medical genetics
33264374 Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks. Odio CD et al. 2020 Sarcoidosis, vasculitis, and diffuse lung diseases
33469341 Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer. Chuo D et al. 2021 Pharmacogenomics and personalized medicine
33610191 Macrophage migration inhibitory factor may play a protective role in osteoarthritis. Liu M et al. 2021 Arthritis research & therapy
33850223 Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population. Luo JY et al. 2021 Scientific reports
34093770 MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma. Qin L et al. 2021 Oncology letters
34533238 Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study. Hernández-Bello J et al. 2021 Journal of clinical laboratory analysis
34834553 Innate-Immunity Genes in Obesity. Mikhailova SV et al. 2021 Journal of personalized medicine
34900076 Association of MIF gene polymorphisms with pemphigus vulgaris: a case-control study with comprehensive review of the literature. Gupta P et al. 2021 International journal of clinical and experimental pathology
35065510 The influence of Interleukin-6, Interleukin-8, Interleukin-10, Interleukin-17, TNF-A, MIF, STAT3 on lung cancer risk in Moroccan population. Kaanane H et al. 2022 Cytokine
35205271 MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD). Guarneri M et al. 2022 Genes
35367937 Correlation of MIF-AS1 polymorphisms with the risk and prognosis of gastric cancer. Ni P et al. 2022 Pathology, research and practice
35372081 Association of Polymorphisms in Inflammation Genes With the Prognosis of Advanced Non-Small Cell Lung Cancer Patients Receiving Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Zhang X et al. 2022 Frontiers in oncology
35450164 Pathophysiological Role of Genetic Factors Associated With Gestational Diabetes Mellitus. Ortega-Contreras B et al. 2022 Frontiers in physiology
35712358 Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris. Hassan MH et al. 2022 Clinical, cosmetic and investigational dermatology
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post761+d5e8e07